|
●
Country:
|
Italy
|
|
●
Package Size:
|
30
|
|
●
Public Price:
|
3614.98 EUR
|
( 66,443,513.15 LBP )
|
|
●
Pack size unit used:
|
30
|
|
●
Cost/Unit:
|
120,4993 EUR
|
( 2,205,606.00 LBP )
|
|
●
Exfactory Price:
|
2190.37 EUR
|
|
●
Pricing Date:
|
17/12/2019
|
|
●
Type:
|
Medicine Authorised
|
|
●
Country:
|
Germany
|
|
●
Package Size:
|
30
|
|
●
Public Price:
|
3371.51 EUR
|
( 61,968,522.38 LBP )
|
|
●
Pack size unit used:
|
30
|
|
●
Cost/Unit:
|
112,3837 EUR
|
( 2,058,565.60 LBP )
|
|
●
Pricing Date:
|
24/10/2020
|
|
●
Type:
|
Medicine Authorised
|
|
●
Country:
|
The Netherlands
|
|
●
Package Size:
|
30
|
|
●
Public Price:
|
2589.22 EUR
|
( 47,589,993.06 LBP )
|
|
●
Pack size unit used:
|
30
|
|
●
Cost/Unit:
|
86,3073 EUR
|
( 1,580,684.30 LBP )
|
|
●
Pharmacy Price:
|
2582.22 EUR
|
( 47461332.711 LBP )
|
|
●
Reference:
|
Zorginstituut Nederland
|
|
●
Pricing Date:
|
15/06/2019
|
|
●
Type:
|
Medicine Authorised
|
|
●
Country:
|
Switzerland
|
|
●
Package Size:
|
30
|
|
●
Public Price:
|
2588.7 CHF
|
( 44,163,869.18 LBP )
|
|
●
Pack size unit used:
|
30
|
|
●
Cost/Unit:
|
86,29 CHF
|
( 1,467,181.50 LBP )
|
|
●
Exfactory Price:
|
2304.28 CHF
|
|
●
Pricing Date:
|
04/04/2021
|
|
●
Type:
|
Medicine Authorised
|
|
●
Country:
|
Denmark
|
|
●
Package Size:
|
30
|
|
●
Public Price:
|
17834.6 DKK
|
( 43,890,415.56 LBP )
|
|
●
Pack size unit used:
|
30
|
|
●
Cost/Unit:
|
594,4867 DKK
|
( 1,461,816.18 LBP )
|
|
●
Pharmacy Price:
|
13254.85 DKK
|
( 32619788.2045 LBP )
|
|
●
Reference:
|
Danish Medicine Agency
|
|
●
Pricing Date:
|
19/05/2021
|
|
●
Type:
|
Medicine Authorised
|
|
●
Country:
|
UK
|
|
●
Package Size:
|
30
|
|
●
Public Price:
|
2167.71 GBP
|
( 43,681,025.64 LBP )
|
|
●
Pack size unit used:
|
30
|
|
●
Cost/Unit:
|
72,257 GBP
|
( 1,450,855.44 LBP )
|
|
●
Reference:
|
DMD
|
|
●
Pricing Date:
|
08/03/2021
|
|
●
Type:
|
Medicine Authorised
|
|
●
Country:
|
Belgium
|
|
●
Package Size:
|
30
|
|
●
Public Price:
|
2331 EUR
|
( 42,843,896.55 LBP )
|
|
●
Pack size unit used:
|
30
|
|
●
Cost/Unit:
|
77,7 EUR
|
( 1,415,263.85 LBP )
|
|
●
Reference:
|
cbip
|
|
●
Pricing Date:
|
02/12/2020
|
|
●
Type:
|
Medicine Authorised
|
|
●
Country:
|
Finland
|
|
●
Package Size:
|
30
|
|
●
Public Price:
|
2299.61 EUR
|
( 42,266,946.78 LBP )
|
|
●
Pack size unit used:
|
30
|
|
●
Cost/Unit:
|
76,6537 EUR
|
( 1,396,883.80 LBP )
|
|
●
Reference:
|
Kela
|
|
●
Pricing Date:
|
22/04/2021
|
|
●
Type:
|
Medicine Authorised
|
|
●
Country:
|
Qatar
|
|
●
Package Size:
|
30
|
|
●
Public Price:
|
10074 QAR
|
( 41,812,741.44 LBP )
|
|
●
Pack size unit used:
|
30
|
|
●
Cost/Unit:
|
335,8 QAR
|
( 1,390,437.60 LBP )
|
|
●
Pharmacy Price:
|
8274.9446 QAR
|
( 34345654.058976 LBP )
|
|
●
Pricing Date:
|
28/01/2021
|
|
●
Type:
|
Medicine Authorised
|
|
●
Country:
|
Ireland
|
|
●
Package Size:
|
30
|
|
●
Public Price:
|
2274.36 EUR
|
( 41,802,850.52 LBP )
|
|
●
Pack size unit used:
|
30
|
|
●
Cost/Unit:
|
75,812 EUR
|
( 1,378,503.75 LBP )
|
|
●
Pricing Date:
|
08/10/2020
|
|
●
Type:
|
Medicine Authorised
|
|
●
Country:
|
Czech Republic
|
|
●
Package Size:
|
30
|
|
●
Public Price:
|
57486.92 CZK
|
( 39,709,664.86 LBP )
|
|
●
Pack size unit used:
|
30
|
|
●
Cost/Unit:
|
1916,2307 CZK
|
( 1,323,496.16 LBP )
|
|
●
Reference:
|
SUKL
|
|
●
Pricing Date:
|
28/02/2020
|
|
●
Type:
|
Medicine Authorised
|
|
●
Country:
|
Spain
|
|
●
Package Size:
|
30
|
|
●
Public Price:
|
2185.34 EUR
|
( 40,166,658.47 LBP )
|
|
●
Pack size unit used:
|
30
|
|
●
Cost/Unit:
|
72,8447 EUR
|
( 1,323,363.60 LBP )
|
|
●
Reference:
|
Agencia Española de Medicamentos y Productos Sanitarios
|
|
●
Pricing Date:
|
06/05/2021
|
|
●
Type:
|
Medicine Authorised
|
|
●
Country:
|
Iceland
|
|
●
Package Size:
|
30
|
|
●
Public Price:
|
353850 ISK
|
( 39,227,811.00 LBP )
|
|
●
Pack size unit used:
|
30
|
|
●
Cost/Unit:
|
11795 ISK
|
( 1,307,593.70 LBP )
|
|
●
Pharmacy Price:
|
279402 ISK
|
( 30974505.72 LBP )
|
|
●
Reference:
|
Icelandic Medicines Agency
|
|
●
Pricing Date:
|
01/04/2020
|
|
●
Type:
|
Medicine Authorised
|
|
●
Country:
|
Abu Dhabi
|
|
●
Package Size:
|
30
|
|
●
Public Price:
|
9413.5 AED
|
( 38,698,521.96 LBP )
|
|
●
Pack size unit used:
|
30
|
|
●
Cost/Unit:
|
313,7833 AED
|
( 1,286,730.48 LBP )
|
|
●
Pharmacy Price:
|
8018.95 AED
|
( 32965582.692 LBP )
|
|
●
Pricing Date:
|
27/01/2021
|
|
●
Type:
|
Medicine Authorised
|
|
●
Country:
|
UAE
|
|
●
Package Size:
|
30's (10's Blister x 3)
|
|
●
Public Price:
|
9413.5 AED
|
( 38,698,521.96 LBP )
|
|
●
Pack size unit used:
|
30
|
|
●
Cost/Unit:
|
313,7833 AED
|
( 1,286,730.48 LBP )
|
|
●
Pharmacy Price:
|
8018.95 AED
|
( 32965582.692 LBP )
|
|
●
Pricing Date:
|
21/08/2019
|
|
●
Type:
|
Medicine Authorised
|
|
●
Country:
|
Oman
|
|
●
Package Size:
|
30
|
|
●
Public Price:
|
970.64 OMR
|
( 38,146,637.32 LBP )
|
|
●
Pack size unit used:
|
30
|
|
●
Cost/Unit:
|
32,3547 OMR
|
( 1,257,616.00 LBP )
|
|
●
Pricing Date:
|
19/02/2021
|
|
●
Type:
|
Medicine Authorised
|
|
●
Country:
|
Sweden
|
|
●
Package Size:
|
30
|
|
●
Public Price:
|
20899.65 SEK
|
( 37,621,668.96 LBP )
|
|
●
Pack size unit used:
|
30
|
|
●
Cost/Unit:
|
696,655 SEK
|
( 1,252,876.56 LBP )
|
|
●
Pharmacy Price:
|
20433.24 SEK
|
( 36782079.6564 LBP )
|
|
●
Pricing Date:
|
27/12/2019
|
|
●
Type:
|
Medicine Non Marketed
|
|
●
Country:
|
Kuweit
|
|
●
Package Size:
|
Boîte de 30
|
|
●
Public Price:
|
756.34 KWD
|
( 37,491,834.31 LBP )
|
|
●
Pack size unit used:
|
30
|
|
●
Cost/Unit:
|
25,2113 KWD
|
( 1,239,252.00 LBP )
|
|
●
Pharmacy Price:
|
638.98 KWD
|
( 31674289.7184 LBP )
|
|
●
Pricing Date:
|
07/02/2021
|
|
●
Type:
|
Medicine Authorised
|
|
●
Country:
|
Cyprus
|
|
●
Package Size:
|
30 TABS
|
|
●
Public Price:
|
1979.02 EUR
|
( 36,374,486.55 LBP )
|
|
●
Pack size unit used:
|
30
|
|
●
Cost/Unit:
|
65,9673 EUR
|
( 1,194,703.25 LBP )
|
|
●
Reference:
|
Cyprus Minister of Health
|
|
●
Pricing Date:
|
24/03/2021
|
|
●
Type:
|
Medicine Authorised
|
|
●
Country:
|
France
|
|
●
Package Size:
|
30
|
|
●
Public Price:
|
1971.63 EUR
|
( 36,238,657.98 LBP )
|
|
●
Pack size unit used:
|
30
|
|
●
Cost/Unit:
|
65,721 EUR
|
( 1,194,703.25 LBP )
|
|
●
Reference:
|
ansm
|
|
●
Pricing Date:
|
15/05/2021
|
|
●
Type:
|
Medicine Authorised
|
|
●
Country:
|
Norway
|
|
●
Package Size:
|
30
|
|
●
Public Price:
|
20640.8 NOK
|
( 35,714,157.02 LBP )
|
|
●
Pack size unit used:
|
30
|
|
●
Cost/Unit:
|
688,0267 NOK
|
( 1,190,425.76 LBP )
|
|
●
Pharmacy Price:
|
16160.44 NOK
|
( 27961924.5188 LBP )
|
|
●
Reference:
|
Norwegian Medicine Agency
|
|
●
Pricing Date:
|
01/04/2020
|
|
●
Type:
|
Medicine Authorised
|
|
●
Country:
|
Greece
|
|
●
Package Size:
|
30
|
|
●
Public Price:
|
1777.2 EUR
|
( 32,665,024.86 LBP )
|
|
●
Pack size unit used:
|
30
|
|
●
Cost/Unit:
|
59,24 EUR
|
( 1,084,422.95 LBP )
|
|
●
Exfactory Price:
|
1592.12 EUR
|
|
●
Pharmacy Price:
|
1616 EUR
|
( 29702160.8 LBP )
|
|
●
Reference:
|
National Organization for Medicines
|
|
●
Pricing Date:
|
25/02/2021
|
|
●
Type:
|
Medicine Authorised
|
|
●
Country:
|
Bahrain
|
|
●
Package Size:
|
30
|
|
●
Public Price:
|
819.38 BHD
|
( 32,874,156.52 LBP )
|
|
●
Pack size unit used:
|
30
|
|
●
Cost/Unit:
|
27,3127 BHD
|
( 1,083,260.79 LBP )
|
|
●
Reference:
|
nhra
|
|
●
Pricing Date:
|
09/02/2021
|
|
●
Type:
|
Medicine Authorised
|
|
●
Country:
|
KSA
|
|
●
Package Size:
|
30
|
|
●
Public Price:
|
7889.45 SAR
|
( 31,797,481.49 LBP )
|
|
●
Pack size unit used:
|
30
|
|
●
Cost/Unit:
|
262,9817 SAR
|
( 1,055,959.56 LBP )
|
|
●
Reference:
|
sfda
|
|
●
Pricing Date:
|
16/01/2021
|
|
●
Type:
|
Medicine Authorised
|
|
●
Country:
|
Jordan
|
|
●
Package Size:
|
30
|
|
●
Public Price:
|
1192.48 JOD
|
( 25,447,749.77 LBP )
|
|
●
Pack size unit used:
|
30
|
|
●
Cost/Unit:
|
39,7493 JOD
|
( 832,267.41 LBP )
|
|
●
Pharmacy Price:
|
1146.62 JOD
|
( 24469088.6578 LBP )
|
|
●
Reference:
|
JFDA
|
|
●
Pricing Date:
|
02/01/2021
|
|
●
Type:
|
Medicine Authorised
|
|
●
Country:
|
Egypt
|
|
●
Package Size:
|
30
|
|
●
Public Price:
|
10600 EGP
|
( 10,177,060.00 LBP )
|
|
●
Pack size unit used:
|
30
|
|
●
Cost/Unit:
|
353,3333 EGP
|
( 338,915.30 LBP )
|
|
●
Pricing Date:
|
20/11/2019
|
|
●
Type:
|
Medicine Authorised
|
|
●
Country:
|
Turkey
|
|
●
Package Size:
|
30
|
|
●
Public Price:
|
4901.06 TRY
|
( 9,413,416.93 LBP )
|
|
●
Pack size unit used:
|
30
|
|
●
Cost/Unit:
|
163,3687 TRY
|
( 313,072.47 LBP )
|
|
●
Pricing Date:
|
28/10/2020
|
|
●
Type:
|
Medicine Authorised
|
|
●
Country:
|
Lebanon
|
|
●
Form:
|
Tablet, Film-Coated
|
|
●
Package Size:
|
Box of 30
|
|
●
Public Price:
|
2326878 LBP
|
( 2,326,878.00 LBP )
|
|
●
Pack size unit used:
|
30
|
|
●
Cost/Unit:
|
77562,6 LBP
|
( 77,562.00 LBP )
|
|
●
Pricing Date:
|
10/01/2024
|
|
●
Country:
|
Portugal
|
|
●
Package Size:
|
30
|
|
●
Reference:
|
Autoridade Nacional do Medicamento e Produtos de Saúde
|
|
●
Pricing Date:
|
22/04/2019
|
|
●
Type:
|
Medicine Authorised
|
|
●
Country:
|
New Zealand
|
|
●
Package Size:
|
30 tab
|
|
●
Exfactory Price:
|
1700 NZD
|
|
●
Reference:
|
New Zealand Pharmaceutical Management Agency
|
|
●
Pricing Date:
|
01/04/2020
|
|
●
Type:
|
Medicine Authorised
|
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK :
(Adults)
|
●
Cost/Unit:
|
120,4993 EUR
|
( 2,205,606.00 LBP )
|
|
● Cost/Day:
|
120,5 EUR
|
( 2,205,606.00 LBP )
|
|
●
Cost/Month:
|
3615 EUR
|
( 66,443,880.75 LBP )
|
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK :
(Adults)
|
●
Cost/Unit:
|
112,3837 EUR
|
( 2,058,565.60 LBP )
|
|
● Cost/Day:
|
112,38 EUR
|
( 2,058,565.60 LBP )
|
|
●
Cost/Month:
|
3371,4 EUR
|
( 61,959,148.55 LBP )
|
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK :
(Adults)
|
●
Cost/Unit:
|
86,3073 EUR
|
( 1,580,684.30 LBP )
|
|
● Cost/Day:
|
86,31 EUR
|
( 1,580,684.30 LBP )
|
|
●
Cost/Month:
|
2589,3 EUR
|
( 47,585,949.45 LBP )
|
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK :
(Adults)
|
●
Cost/Unit:
|
86,29 CHF
|
( 1,467,181.50 LBP )
|
|
● Cost/Day:
|
86,29 CHF
|
( 1,467,181.50 LBP )
|
|
●
Cost/Month:
|
2588,7 CHF
|
( 44,151,927.00 LBP )
|
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK :
(Adults)
|
●
Cost/Unit:
|
594,4867 DKK
|
( 1,461,816.18 LBP )
|
|
● Cost/Day:
|
594,49 DKK
|
( 1,461,816.18 LBP )
|
|
●
Cost/Month:
|
17834,7 DKK
|
( 43,888,938.98 LBP )
|
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK :
(Adults)
|
●
Cost/Unit:
|
72,257 GBP
|
( 1,450,855.44 LBP )
|
|
● Cost/Day:
|
72,26 GBP
|
( 1,450,855.44 LBP )
|
|
●
Cost/Month:
|
2167,8 GBP
|
( 43,666,718.59 LBP )
|
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK :
(Adults)
|
●
Cost/Unit:
|
77,7 EUR
|
( 1,415,263.85 LBP )
|
|
● Cost/Day:
|
77,7 EUR
|
( 1,415,263.85 LBP )
|
|
●
Cost/Month:
|
2331 EUR
|
( 42,843,896.55 LBP )
|
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK :
(Adults)
|
●
Cost/Unit:
|
76,6537 EUR
|
( 1,396,883.80 LBP )
|
|
● Cost/Day:
|
76,65 EUR
|
( 1,396,883.80 LBP )
|
|
●
Cost/Month:
|
2299,5 EUR
|
( 42,255,734.95 LBP )
|
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK :
(Adults)
|
●
Cost/Unit:
|
335,8 QAR
|
( 1,390,437.60 LBP )
|
|
● Cost/Day:
|
335,8 QAR
|
( 1,390,437.60 LBP )
|
|
●
Cost/Month:
|
10074 QAR
|
( 41,812,741.44 LBP )
|
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK :
(Adults)
|
●
Cost/Unit:
|
75,812 EUR
|
( 1,378,503.75 LBP )
|
|
● Cost/Day:
|
75,81 EUR
|
( 1,378,503.75 LBP )
|
|
●
Cost/Month:
|
2274,3 EUR
|
( 41,796,233.70 LBP )
|
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK :
(Adults)
|
●
Cost/Unit:
|
1916,2307 CZK
|
( 1,323,496.16 LBP )
|
|
● Cost/Day:
|
1916,23 CZK
|
( 1,323,496.16 LBP )
|
|
●
Cost/Month:
|
57486,9 CZK
|
( 39,709,029.36 LBP )
|
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK :
(Adults)
|
●
Cost/Unit:
|
72,8447 EUR
|
( 1,323,363.60 LBP )
|
|
● Cost/Day:
|
72,84 EUR
|
( 1,323,363.60 LBP )
|
|
●
Cost/Month:
|
2185,2 EUR
|
( 40,160,409.25 LBP )
|
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK :
(Adults)
|
●
Cost/Unit:
|
11795 ISK
|
( 1,307,593.70 LBP )
|
|
● Cost/Day:
|
11795 ISK
|
( 1,307,593.70 LBP )
|
|
●
Cost/Month:
|
353850 ISK
|
( 39,227,811.00 LBP )
|
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK :
(Adults)
|
●
Cost/Unit:
|
313,7833 AED
|
( 1,286,730.48 LBP )
|
|
● Cost/Day:
|
313,78 AED
|
( 1,286,730.48 LBP )
|
|
●
Cost/Month:
|
9413,4 AED
|
( 38,696,466.48 LBP )
|
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK :
(Adults)
|
●
Cost/Unit:
|
313,7833 AED
|
( 1,286,730.48 LBP )
|
|
● Cost/Day:
|
313,78 AED
|
( 1,286,730.48 LBP )
|
|
●
Cost/Month:
|
9413,4 AED
|
( 38,696,466.48 LBP )
|
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK :
(Adults)
|
●
Cost/Unit:
|
32,3547 OMR
|
( 1,257,616.00 LBP )
|
|
● Cost/Day:
|
32,35 OMR
|
( 1,257,616.00 LBP )
|
|
●
Cost/Month:
|
970,5 OMR
|
( 38,121,485.00 LBP )
|
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK :
(Adults)
|
●
Cost/Unit:
|
696,655 SEK
|
( 1,252,876.56 LBP )
|
|
● Cost/Day:
|
696,66 SEK
|
( 1,252,876.56 LBP )
|
|
●
Cost/Month:
|
20899,8 SEK
|
( 37,620,498.89 LBP )
|
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK :
(Adults)
|
●
Cost/Unit:
|
25,2113 KWD
|
( 1,239,252.00 LBP )
|
|
● Cost/Day:
|
25,21 KWD
|
( 1,239,252.00 LBP )
|
|
●
Cost/Month:
|
756,3 KWD
|
( 37,474,980.48 LBP )
|
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK :
(Adults)
|
●
Cost/Unit:
|
65,9673 EUR
|
( 1,194,703.25 LBP )
|
|
● Cost/Day:
|
65,97 EUR
|
( 1,194,703.25 LBP )
|
|
●
Cost/Month:
|
1979,1 EUR
|
( 36,374,118.95 LBP )
|
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK :
(Adults)
|
●
Cost/Unit:
|
65,721 EUR
|
( 1,194,703.25 LBP )
|
|
● Cost/Day:
|
65,72 EUR
|
( 1,194,703.25 LBP )
|
|
●
Cost/Month:
|
1971,6 EUR
|
( 36,227,078.55 LBP )
|
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK :
(Adults)
|
●
Cost/Unit:
|
688,0267 NOK
|
( 1,190,425.76 LBP )
|
|
● Cost/Day:
|
688,03 NOK
|
( 1,190,425.76 LBP )
|
|
●
Cost/Month:
|
20640,9 NOK
|
( 35,712,772.80 LBP )
|
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK :
(Adults)
|
●
Cost/Unit:
|
59,24 EUR
|
( 1,084,422.95 LBP )
|
|
● Cost/Day:
|
59,24 EUR
|
( 1,084,422.95 LBP )
|
|
●
Cost/Month:
|
1777,2 EUR
|
( 32,661,348.85 LBP )
|
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK :
(Adults)
|
●
Cost/Unit:
|
27,3127 BHD
|
( 1,083,260.79 LBP )
|
|
● Cost/Day:
|
27,31 BHD
|
( 1,083,260.79 LBP )
|
|
●
Cost/Month:
|
819,3 BHD
|
( 32,858,910.63 LBP )
|
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK :
(Adults)
|
●
Cost/Unit:
|
262,9817 SAR
|
( 1,055,959.56 LBP )
|
|
● Cost/Day:
|
262,98 SAR
|
( 1,055,959.56 LBP )
|
|
●
Cost/Month:
|
7889,4 SAR
|
( 31,795,667.82 LBP )
|
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK :
(Adults)
|
●
Cost/Unit:
|
39,7493 JOD
|
( 832,267.41 LBP )
|
|
● Cost/Day:
|
39,75 JOD
|
( 832,267.41 LBP )
|
|
●
Cost/Month:
|
1192,5 JOD
|
( 25,437,506.48 LBP )
|
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK :
(Adults)
|
●
Cost/Unit:
|
353,3333 EGP
|
( 338,915.30 LBP )
|
|
● Cost/Day:
|
353,33 EGP
|
( 338,915.30 LBP )
|
|
●
Cost/Month:
|
10599,9 EGP
|
( 10,176,099.90 LBP )
|
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK :
(Adults)
|
●
Cost/Unit:
|
163,3687 TRY
|
( 313,072.47 LBP )
|
|
● Cost/Day:
|
163,37 TRY
|
( 313,072.47 LBP )
|
|
●
Cost/Month:
|
4901,1 TRY
|
( 9,413,301.69 LBP )
|
Locally advanced or metastatic non-small cell lung cancer (NSCLC) with activating mutations of EGFR-TK :
(Adults)
|
●
Cost/Unit:
|
77562,6 LBP
|
( 77,562.00 LBP )
|
|
● Cost/Day:
|
77562,6 LBP
|
( 77,562.00 LBP )
|
|
●
Cost/Month:
|
2326878 LBP
|
( 2,326,878.00 LBP )
|
Prices are provided in Dollar ($)
You have to register to view this info
You have to register to view this info
